58 related articles for article (PubMed ID: 17012685)
1. Brain dopamine d1 receptors in twins discordant for schizophrenia.
Hirvonen J; van Erp TG; Huttunen J; Aalto S; Någren K; Huttunen M; Lönnqvist J; Kaprio J; Cannon TD; Hietala J
Am J Psychiatry; 2006 Oct; 163(10):1747-53. PubMed ID: 17012685
[TBL] [Abstract][Full Text] [Related]
2. Monozygotic twins discordant for schizophrenia differ in maturation and synaptic transmission.
Stern S; Zhang L; Wang M; Wright R; Rosh I; Hussein Y; Stern T; Choudhary A; Tripathi U; Reed P; Sadis H; Nayak R; Shemen A; Agarwal K; Cordeiro D; Peles D; Hang Y; Mendes APD; Baul TD; Roth JG; Coorapati S; Boks MP; McCombie WR; Hulshoff Pol H; Brennand KJ; Réthelyi JM; Kahn RS; Marchetto MC; Gage FH
Mol Psychiatry; 2024 May; ():. PubMed ID: 38704507
[TBL] [Abstract][Full Text] [Related]
3. Phospholipids and insulin resistance in psychosis: a lipidomics study of twin pairs discordant for schizophrenia.
Orešič M; Seppänen-Laakso T; Sun D; Tang J; Therman S; Viehman R; Mustonen U; van Erp TG; Hyötyläinen T; Thompson P; Toga AW; Huttunen MO; Suvisaari J; Kaprio J; Lönnqvist J; Cannon TD
Genome Med; 2012 Jan; 4(1):1. PubMed ID: 22257447
[TBL] [Abstract][Full Text] [Related]
4. Schizophrenia Animal Modeling with Epidermal Growth Factor and Its Homologs: Their Connections to the Inflammatory Pathway and the Dopamine System.
Sotoyama H; Namba H; Tohmi M; Nawa H
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830741
[TBL] [Abstract][Full Text] [Related]
5. The interplay of dopamine metabolism abnormalities and mitochondrial defects in the pathogenesis of schizophrenia.
Xu H; Yang F
Transl Psychiatry; 2022 Nov; 12(1):464. PubMed ID: 36344514
[TBL] [Abstract][Full Text] [Related]
6. Dopamine D1R Receptor Stimulation as a Mechanistic Pro-cognitive Target for Schizophrenia.
Abi-Dargham A; Javitch JA; Slifstein M; Anticevic A; Calkins ME; Cho YT; Fonteneau C; Gil R; Girgis R; Gur RE; Gur RC; Grinband J; Kantrowitz J; Kohler C; Krystal J; Murray J; Ranganathan M; Santamauro N; Van Snellenberg J; Tamayo Z; Wolf D; ; Gray D; Lieberman J
Schizophr Bull; 2022 Jan; 48(1):199-210. PubMed ID: 34423843
[TBL] [Abstract][Full Text] [Related]
7. Physiology and Therapeutic Potential of SK, H, and M Medium AfterHyperPolarization Ion Channels.
Dwivedi D; Bhalla US
Front Mol Neurosci; 2021; 14():658435. PubMed ID: 34149352
[TBL] [Abstract][Full Text] [Related]
8. Dopamine and glutamate in schizophrenia: biology, symptoms and treatment.
McCutcheon RA; Krystal JH; Howes OD
World Psychiatry; 2020 Feb; 19(1):15-33. PubMed ID: 31922684
[TBL] [Abstract][Full Text] [Related]
9. Transdiagnostic Dysfunctions in Brain Modules Across Patients with Schizophrenia, Bipolar Disorder, and Major Depressive Disorder: A Connectome-Based Study.
Ma Q; Tang Y; Wang F; Liao X; Jiang X; Wei S; Mechelli A; He Y; Xia M
Schizophr Bull; 2020 Apr; 46(3):699-712. PubMed ID: 31755957
[TBL] [Abstract][Full Text] [Related]
10. D1-Dopamine Receptor Availability in First-Episode Neuroleptic Naive Psychosis Patients.
Stenkrona P; Matheson GJ; Halldin C; Cervenka S; Farde L
Int J Neuropsychopharmacol; 2019 Jul; 22(7):415-425. PubMed ID: 30958880
[TBL] [Abstract][Full Text] [Related]
11. [
Stenkrona P; Matheson GJ; Cervenka S; Sigray PP; Halldin C; Farde L
EJNMMI Res; 2018 Aug; 8(1):74. PubMed ID: 30069645
[TBL] [Abstract][Full Text] [Related]
12. The Role of Genes, Stress, and Dopamine in the Development of Schizophrenia.
Howes OD; McCutcheon R; Owen MJ; Murray RM
Biol Psychiatry; 2017 Jan; 81(1):9-20. PubMed ID: 27720198
[TBL] [Abstract][Full Text] [Related]
13. Contribution of non-genetic factors to dopamine and serotonin receptor availability in the adult human brain.
Borg J; Cervenka S; Kuja-Halkola R; Matheson GJ; Jönsson EG; Lichtenstein P; Henningsson S; Ichimiya T; Larsson H; Stenkrona P; Halldin C; Farde L
Mol Psychiatry; 2016 Aug; 21(8):1077-84. PubMed ID: 26821979
[TBL] [Abstract][Full Text] [Related]
14. Stress Impairs Prefrontal Cortical Function via D1 Dopamine Receptor Interactions With Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels.
Gamo NJ; Lur G; Higley MJ; Wang M; Paspalas CD; Vijayraghavan S; Yang Y; Ramos BP; Peng K; Kata A; Boven L; Lin F; Roman L; Lee D; Arnsten AF
Biol Psychiatry; 2015 Dec; 78(12):860-70. PubMed ID: 25731884
[TBL] [Abstract][Full Text] [Related]
15. Glutamate and dopamine in schizophrenia: an update for the 21st century.
Howes O; McCutcheon R; Stone J
J Psychopharmacol; 2015 Feb; 29(2):97-115. PubMed ID: 25586400
[TBL] [Abstract][Full Text] [Related]
16. Morphological changes in gray matter volume correlate with catechol-O-methyl transferase gene Val158Met polymorphism in first-episode treatment-naïve patients with schizophrenia.
Li ML; Xiang B; Li YF; Hu X; Wang Q; Guo WJ; Lei W; Huang CH; Zhao LS; Li N; Ren HY; Wang HY; Ma XH; Deng W; Li T
Neurosci Bull; 2015 Feb; 31(1):31-42. PubMed ID: 25564193
[TBL] [Abstract][Full Text] [Related]
17. Translational epidemiology in psychiatry: linking population to clinical and basic sciences.
Weissman MM; Brown AS; Talati A
Arch Gen Psychiatry; 2011 Jun; 68(6):600-8. PubMed ID: 21646577
[TBL] [Abstract][Full Text] [Related]
18. Catechol-o-methyl transferase (COMT) val158met polymorphism and adolescent cortical development in patients with childhood-onset schizophrenia, their non-psychotic siblings, and healthy controls.
Raznahan A; Greenstein D; Lee Y; Long R; Clasen L; Gochman P; Addington A; Giedd JN; Rapoport JL; Gogtay N
Neuroimage; 2011 Aug; 57(4):1517-23. PubMed ID: 21620981
[TBL] [Abstract][Full Text] [Related]
19. Dysfunctional brain networks and genetic risk for schizophrenia: specific neurotransmitter systems.
Hirvonen J; Hietala J
CNS Neurosci Ther; 2011 Apr; 17(2):89-96. PubMed ID: 21199447
[TBL] [Abstract][Full Text] [Related]
20. Basal ganglia pathology in schizophrenia: dopamine connections and anomalies.
Perez-Costas E; Melendez-Ferro M; Roberts RC
J Neurochem; 2010 Apr; 113(2):287-302. PubMed ID: 20089137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
